Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × SCLC × 30 days × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 90 Carcinoma, Non-Small-Cell Lung 80 Prostatic Neoplasms 73 Multiple Myeloma 57 Leukemia, Myeloid, Acute 49 Neoplasms 46 Colorectal Neoplasms 43 Lung Neoplasms 42 Neoplasm Metastasis 35 Melanoma 33 Pancreatic Neoplasms 32 Ovarian Neoplasms 32 Triple Negative Breast Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 31 Lymphoma 30 Brain Neoplasms 28 Urinary Bladder Neoplasms 26 Carcinoma, Renal Cell 26 Carcinoma, Hepatocellular 26 Recurrence 24 Leukemia, Lymphocytic, Chronic, B-Cell 22 Sarcoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Glioblastoma 20 Stomach Neoplasms 19 Lymphoma, Follicular 19 Hematologic Neoplasms 19 Glioma 19 Endometrial Neoplasms 19 Small Cell Lung Carcinoma 18

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07110103 2026-02-27

JACKPOT38

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡